{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-050756","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.755349+00:00","generated_at":"2026-05-20T02:15:26.552087+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Oruka Therapeutics shareholders elect directors, ratify auditor, approve say-on-pay","bullets":["Elected Carl Dambkowski (26,047,914 for) and Peter Harwin (25,935,823 for) as Class I directors.","Ratified PricewaterhouseCoopers as independent auditor for FY 2025 (26,781,030 for, 1,848 against).","Non-binding advisory vote approved named executive officer compensation (25,824,834 for, 88,740 against).","Non-binding vote favored annual frequency for future say-on-pay; board adopted annual frequency.","All proposals passed; broker non-votes of 732,854 on director and compensation proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-050756","json":"https://secwatch.observer/filing/0001213900-25-050756.json","markdown":"https://secwatch.observer/filing/0001213900-25-050756.md","text":"https://secwatch.observer/filing/0001213900-25-050756.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000121390025050756/0001213900-25-050756-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000121390025050756/ea0244429-8k_oruka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:15:26.552087+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}